News
Guggenheim’s Jason Cassorla gave Cigna’s outlook a caffeine jolt, raising the target price to $388 while maintaining a “Buy” ...
Each of the six major national insurers turned a profit in the first quarter of 2025, though financial pressures related to ...
Express Scripts, Cigna, UnitedHealthcare, CVS Caremark and Optum Rx are among the payers that have added Yesintek to their ...
Cigna Group is contending with elevated industry-wide medical costs that are expected to weigh on its Healthcare segment in 2025, according to CFRA, which downgraded the stock to Hold in a note ...
FARM FRESH is revamping its coaching staff with hopes of changing its fortunes in the 2025 Premier Volleyball League seasons. After quietly bringing in veteran internationalist Fabio Menta as ...
Cigna delivered a knockout first quarter in 2025, prompting Raymond James to boost its price target from $360 to $385. The ...
Shares of Cigna Group (CI) rose on Monday after announcing upbeat Q1 results. Analysts are optimistic about the company's growth and raised guidance.
The early results for stop-loss claims, or claims for catastrophic losses, are in line with the insurer's expectations, ...
Shobana starrer earning praise across Kerala, has now been hit by a piracy scandal. A pirated copy of the film was reportedly ...
THE Cignal HD Spikers tapped former De La Salle University and defunct F2 Logistics standout Tine Tiamzon as part of their revamp in preparation for the 2025 Premier Volleyball League season. Ms.
Biocon Biologics secures market access agreements for Yesintek, a biosimilar to Stelara, for treating autoimmune diseases in ...
Perry Cohen, Pharm.D., a longtime member of the Managed Healthcare Executive editorial advisory board, is host of the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results